Three IPOs to hit Dalal Street tomorrow, total fund raising over Rs 1,600 crore
Concord Biotech will be the first to raise Rs 1,550.6 crore through a maiden market offering. Mainboard section.
Money Poise
The market will witness three IPOs available for subscription on the penultimate day of the week on August 4. They plan to raise about Rs 1,600 crore in total.
Concord Biotech, a biotechnology firm, plans to be the first of these companies to go public, with an initial public offering expected to raise Rs 1,550.6 crore. This part comes directly from the motherboard.
Helix Investment Holdings Pte Limited, backed by Quadria Capital, is selling its whole 20% investment (2.09 crore shares) and withdrawing from the Ahmedabad-based pharmaceutical company in this IPO.
Thus, the investment firm sponsored by Rakesh Jhunjhunwala's late RARE Enterprises will not benefit monetarily from the offer.
The offer price range has been set at Rs 705-741 per share, with the deadline set for August 8.
Up to 10,000 equity shares were set aside in the aforementioned offer for firm personnel. In comparison to the final offer price, they will receive these shares at a discount of Rs 70 each.
SME Segment
The other two initial public offerings (IPOs) will come from smaller and medium-sized businesses. IT solutions and consultancy firm Yudiz Solutions will be the second IPO opening on April 4, to collect Rs 44.84 crore at higher price band.
There is no offer for sale component to the IPO; instead, a total of 27.17 million new equity shares will be issued.
The price range for the book building offer, which ends on 8th August, is Rs 162-165 per share.
Acquisition, new product and technology development, networking and cabling, and corporate branding and marketing will all benefit from the proceeds of the new issuance after IPO costs are deducted. The funds are needed for both capital expenditures and operating expenses.
Sangani Hospitals, the third IPO, would sell 37.92 million equity shares to the public for Rs 15.17 crore between August 4 and 8.
The price range for this small and medium-sized enterprise (SME) issue is Rs 37–40.
Only current issues are included in this offer. The profits from the offering will be used for general corporate objectives as well as hospital expansion.
Also Read : Nifty ends the day below 19,400, buy-on-dips pushes Sensex close to 65,250
.jpeg?updatedAt=1701704345219)
